WCBA
SYNH

Weaver C. Barksdale & Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$12K Buy
269
+120
+81% +$5.61K 0.01% 257
2017
Q3 		$8K Buy
149
+10
+7% +$558 0.01% 322
2017
Q2 		$8K Buy
+139
New +$7.22K 0.01% 314

Other funds holding SYNH

THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weaver C. Barksdale & Associates's SYNH Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 81% in Q4 2017, buying an estimated $5.61K and bringing the position to 269 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #257.

Weaver C. Barksdale & Associates first reported a position in SYNH in Q2 2017 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

  • Weaver C. Barksdale & Associates held 269 shares of Syneos Health, Inc. Class A Common Stock worth $12K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 120 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $5.61K.
  • Syneos Health, Inc. Class A Common Stock made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #257 holding.
  • Weaver C. Barksdale & Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.